City
Epaper

Centre to receive 1 cr doses of Zydus Cadila's Covid vaccine ZyCoV-D by December: Sources

By ANI | Updated: November 18, 2021 22:15 IST

Pharmaceutical company Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India by December, government sources said on Thursday.

Open in App

Pharmaceutical company Zydus Cadila will supply 1 crore doses of ZyCoV-D, the world's first Plasmid DNA COVID-19 vaccine, to the Government of India by December, government sources said on Thursday.

The Centre has placed an initial order for one crore doses of the vaccine, they added.

Earlier, The Centre had placed an order to supply one crore doses of ZyCoV-D at Rs 265 per dose and the needle-free applicator being offered at Rs 93 per dose, excluding GST.

ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus. It is also the first COVID-19 vaccine that is needle-free and administered using PharmaJet, a needle-free applicator to ensure painless intradermal vaccine delivery which also leads to a significant reduction in any kind of major side effects.

ZyCoV-D has shown good stability at temperatures of around 25 degrees for atleast three months. The thermostability of the vaccine will help in easy transportation and storage of the vaccine without any problems of fluctuations in temperature.

For prolonged use, a temperature of 2-8 degrees is sufficient. Also being a DNA plasmid vaccine, ZyCoV-D doesn't have any problem associated with vector-based immunity. The DNA Plasmid platform allows generating new constructs quickly to deal with mutations in the virus.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Cadila Healthcare
Open in App

Related Stories

BusinessZydus gets USFDA's final nod to market antifungal Micafungin for injection

HealthZydus Cadila seeks DCGI approval for oral pill to treat anemia

NationalZydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney patients

NationalZydus Cadila receives final approval from USFDA for Glycopyrrolate injection

NationalCentre to purchase 1 crore doses of Zydus Cadila's COVID-19 vaccine at Rs 265 each

National Realted Stories

NationalRajnath Singh to skip Russia visit amid escalating tensions between India-Pakistan

NationalUnion Minister refuses to accept bouquets at Surat event till 'India avenges Pahalgam attack'

NationalEAM Jaishankar discusses Pahalgam terror attack with Russian Foreign Minister Lavrov

NationalResidents in Dehradun reap benefits of Jan Aushadhi Kendra, express gratitude to Modi govt

NationalBharatiya Kisan Union (Ekta-Sidhupur) protests against Punjab govt for not giving compensation for destroyed crops